Novi vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

53 providers verified independently·Independent researchHow we rank →

Novi beats Oak Longevity overall, scoring 7.8/10 vs 7.5/10. Oak Longevity is more affordable at $119/mo vs $133/mo. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side look at Novi and Oak Longevity to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

Novi

#10 of 53
7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

Oak Longevity

#23 of 53
7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.

Visit Oak Longevity
FeatureNoviOak Longevity
Why each oneCombination of six named clinicians (most compounded-only platforms disclose zero or one), month-to-month billing with no commitment, and aggressive promotional pricing as low as $99/mo on the offer landing, a flexibility-and-headcount profile most direct competitors at this price tier do not match.The no-subscription billing model, patients are not auto-charged each month and renew manually. Combined with the broadest medication mix (compounded GLP-1s + oral Wegovy + brand-name + longevity peptides), Oak occupies a unique position as a 'menu' platform vs. the typical single-product flow.
Our Score7.8/107.5/10
Starting Price$133/mo$119/mo
Medication TypeCompoundedBoth
Insurance AcceptedNoNo
Best ForCash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offerBudget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Watch out forCompounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formatsBrand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
Ranking#10#23
Get startedVisit NoviVisit Oak Longevity

Pros & Cons Compared

Novi

Pros

  • +Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
  • +Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
  • +Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
  • +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
  • +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
  • +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

  • Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
  • Founding year, headquarters city, and corporate ownership are not publicly disclosed
  • Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
  • Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
  • Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
  • Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Oak Longevity

Pros

  • +$133/mo for compounded semaglutide is among the cheapest entries on the market, Sesame Care ($99) is lower, but Oak undercuts most mid-tier platforms
  • +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
  • +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
  • +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
  • +Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
  • +Free shipping and free health coaching included in every program

Cons

  • Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare sells Wegovy direct at $349/mo and LillyDirect has Zepbound at $299/mo. Use Oak for its compounded tiers and buy brand-name direct
  • No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
  • The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
  • The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
  • Newer brand without disclosed company history, founding date, or executive team on landing pages
  • Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our Verdict

Novi edges out Oak Longevity with a score of 7.8/10 vs 7.5/10. If budget is your priority, Oak Longevity is from $119/mo compared to Novi from $133/mo. Oak Longevity offers both brand-name and compounded medications, giving you more flexibility. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).

Cheapest in our index

Embody

$69/mo flat rate · 7.3/10 · Compounded

Both Novi and Oak Longevity start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.

Try Novi

Starting at $133/mo

Visit Novi

Try Oak Longevity

Starting at $119/mo

Visit Oak Longevity

Related comparisons

Other matchups readers comparing Novi or Oak Longevity tend to look at next.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.